Assessment of Azeliragon QTc Liability Through Integrated, Model‐Based Concentration QTc Analysis.
Saved in:
| Title: | Assessment of Azeliragon QTc Liability Through Integrated, Model‐Based Concentration QTc Analysis. |
|---|---|
| Authors: | Burstein, Aaron H.1 (AUTHOR) aburstein@vtvtherapeutics.com, Brantley, Scott J.2 (AUTHOR), Dunn, Imogene1 (AUTHOR), Altstiel, Larry D.3 (AUTHOR), Schmith, Virginia1 (AUTHOR) |
| Source: | Clinical Pharmacology in Drug Development. May2019, Vol. 8 Issue 4, p426-435. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 136173881 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Assessment of Azeliragon QTc Liability Through Integrated, Model‐Based Concentration QTc Analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Burstein%2C+Aaron+H%2E%22">Burstein, Aaron H.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> aburstein@vtvtherapeutics.com</i><br /><searchLink fieldCode="AR" term="%22Brantley%2C+Scott+J%2E%22">Brantley, Scott J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dunn%2C+Imogene%22">Dunn, Imogene</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Altstiel%2C+Larry+D%2E%22">Altstiel, Larry D.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmith%2C+Virginia%22">Schmith, Virginia</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Clinical+Pharmacology+in+Drug+Development%22">Clinical Pharmacology in Drug Development</searchLink>. May2019, Vol. 8 Issue 4, p426-435. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=136173881 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpdd.689 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 426 Titles: – TitleFull: Assessment of Azeliragon QTc Liability Through Integrated, Model‐Based Concentration QTc Analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burstein, Aaron H. – PersonEntity: Name: NameFull: Brantley, Scott J. – PersonEntity: Name: NameFull: Dunn, Imogene – PersonEntity: Name: NameFull: Altstiel, Larry D. – PersonEntity: Name: NameFull: Schmith, Virginia IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: May2019 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 2160763X Numbering: – Type: volume Value: 8 – Type: issue Value: 4 Titles: – TitleFull: Clinical Pharmacology in Drug Development Type: main |
| ResultId | 1 |